Emerging forms of viral uveitis in the developing world

International Ophthalmology Clinics

Volumn 50, Issue 2, 2010, Pages 155-171

  Jap, Aliza ^a   Chee, Soon Phaik ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID DERIVATIVE; FOSCARNET; GANCICLOVIR; INTERFERON; PREDNISOLONE; TRIFURIDINE; UNCLASSIFIED DRUG; VALACICLOVIR; VALGANCICLOVIR; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; BONE MARROW TOXICITY; CATARACT; CHEMOTHERAPY INDUCED EMESIS; CHIKUNGUNYA ALPHAVIRUS; CHIKUNGUNYA INFECTION; CLINICAL FEATURE; CONFUSION; CORNEA ULCER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; ENDOPHTHALMITIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GEOGRAPHIC DISTRIBUTION; HEMOLYTIC UREMIC SYNDROME; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES VIRUS; HERPES ZOSTER; HERPETIC IRIDOCYCLITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECOVERY UVEITIS; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; IRIDOCYCLITIS; KERATITIS; KIDNEY DYSFUNCTION; KIRISAWA UVEITIS; METABOLIC ACIDOSIS; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OPHTHALMOSCOPY; PENILE ULCERATION; PENIS DISEASE; PREVALENCE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINOPEXY; REVIEW; RHEGMATOGENOUS RETINAL DETACHMENT; RUBELLA; SEIZURE; SEROPREVALENCE; SLIT LAMP; STROMAL KERATITIS; THROMBOCYTOPENIA; THROMBOPHLEBITIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT RESPONSE; UVEITIS; VARICELLA ZOSTER VIRUS; VIRAL UVEITIS; VIRUS INFECTION; VIRUS TRANSMISSION; VITREOUS HEMORRHAGE;

ANTERIOR CHAMBER; ANTIVIRAL AGENTS; DEVELOPING COUNTRIES; EYE INFECTIONS, VIRAL; HUMANS; INCIDENCE; UVEA; UVEITIS; VIRUSES;

EID: 77951078233     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181d26f2c     Document Type: Review

References (108)

1. Seale H, MacIntyre CR, Gidding HF, et al. National Survey of cytomegalovirus in Australia. Clin Vaccine Immunol. 2006;13:1181-1184.
2. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006;43:1143-1151.
3. Kothari A, Ramachandran VG, Gupta P, et al. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr. 2002;20:348-351.
4. Kositanont U, Wasi C, Chandanayingyong D, et al. Prevalence of cytomegalovirus antibodies in Thai blood donors. Asian Pac J Allergy Immunol. 1985;3:179-182.
5. Stroffolini T, Ngatchu T, Chiaramonte M, et al. Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon. New Microbiol. 1993;16: 83-85.
6. Wong A, Tan KH, Tee CS, et al. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J. 2000;41:151-155.
7. Ahmed SA, Al-Joudi FS, Zaidah AW, et al. The prevalence of human cytomegalovirus seropositivity among blood donors at the Unit of Blood Transfusion Medicine, Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health. 2006; 37:294-296.
8. Pertel P, Hirschtick R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5:1069-1074.
9. Doan S, Cochereau I, Guvenisik N, et al. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol. 1999;128:250-251.
10. Kestelyn P. The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm. 1999;7:173-177.
11. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect. 2007; 55:464-469.
12. Ausayakhun S, Watananikorn S, Ittipunkul N, et al. Epidemiology of the ocular complications of HIV infection in Chiang Mai. J Med Assoc Thai. 2003;86: 399-406.
13. Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264-271.
14. Bellamy R, Sangeetha S, Paton NI. AIDS-defining illness among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV observational cohort study (SHOCS). BMC Infect Dis. 2004;4:47.
15. Chee SP, Bacsal K, Jap A, et al. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology. 2007;114:798-803.
16. de Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol. 2006;90:852-855.
17. van Boxtel LA, van der Lelij A, van der Meer J, et al. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358-1362.
18. Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115:292-297.
19. Chee SP, Bacsal K, Jap A, et al. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145:834-840.
20. Musch DC, Martin DF, Gordon JF, et al. Treatment of cytomegalovirus retinitis with a sustained release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med. 1997;337:83-90.
21. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4. Visual outcomes. Ophthalmology. 1994;101:1250-1261.
22. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994;112:1531-1539.
23. Martin DF, Kuppermann BD,Wolitz RA, et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med. 1999;340: 1063-1070.
24. Kempen JH, Jabs DA, Wilson LA, et al. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Am J Ophthalmol. 2005;139:1028-1034.
25. Freemann WR, Friedberg DN, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116:713-720.
26. Mitchell SM, Barton K, Lightman S. Corneal endothelial changes in cytomegalovirus retinitis. Eye. 1994;8:41-43.
27. Daicker B. Cytomegalovirus panuveitis with infection of corneo-trabecular endothelium in AIDS. Ophthalmologica. 1988;197:169-175.
28. Banker AS, Arevalo JF, Azen SP, et al. Fluorophotometry in patients with human immunodeficiency virus with and without cytomegalovirus retinitis. Ophthalmology. 1999;106:590-593.
29. KaravellasMP, Lowder CY,MacDonald JC, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis. A new syndrome. Arch Ophthalmol. 1998;116:169-175.
30. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998;125:292-300.
31. Karavellas MP, Azen SP, MacDonald JC, et al. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina. 2001;21:1-9.
32. Kempen JH, Min YI, Freeman WR, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113:684-694.
33. Karavellas MP, Song M, Macdonald JC, et al. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol. 2000;130:57-64.
34. Song MK, Azen SP, Buley A, et al. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003;136:696-702.
35. Chee SP, Jap A. Presumed Fuchs heterochromic and Posner-Schlossman syndrome: comparison of cytomegalovirus positive and negative eyes. Am J Ophthalmol. 2008; 146:883-889.
36. Deayton JR, Wilson P, Sabin CA, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS. 2000;14:1163-1170.
37. Mitchell SM, Membrey WL, Youle MS, et al. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study. Br J Ophthalmol. 1999;83:652-655.
38. Heiden D, Ford N, Wilson D, et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007;4:e334.
39. Teerawattananon K, Iewsakul S, Yenjitr C, et al. Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study. Pharmacoeconomics. 2007;25: 413-428.
40. Adult Prevention and Treatment of Opportunistic Infections Guidelines Working Group. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents [DRAFT]. June 18, 2008; pp 1-289. Available at: http://aidsinfo.nih.gov/contentfiles/Adult-OI.pdf. Accessed on: November 2008.
41. Cytomegalovirus Prophylaxis following Solid Organ Transplants Guideline Team, Cincinnati Children's Hospital Medical Center: Evidence-based Care Guideline for CMV Prophylaxis Following Solid Organ Transplant. Guideline 17, July 6, 2007, pages 1-16. Available at: www.cincinnatichildrens.org/svc/alpha/h/ health-policy/ ev-based/CMV-Transplant.htm.
42. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000;49(No.RR-10).
43. Eid AJ, Arthurs SK, Deziel PJ, et al. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant. 2008;22:162-170.
44. Kuo IC, Kempen JH, Dunn JP. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004;138:338-346.
45. Chung RS, Chua CN. Intravitreal ganciclovir injections in aqueous cytomegalovirus DNA positive hypertensive iritis. Eye. 2006;20:1080.
46. Sira M, Murray PI. Treatment of cytomegalovirus anterior uveitis with oral valaciclovir. Ocul Immunol Inflamm. 2007;15:31-32.
47. Ortega-Larrocea G, Espinosa E, Reyes-Teran G. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy. AIDS. 2005;19:735-738.
48. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000;129:634-639.
49. Henderson HW, Mitchell SM. Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol. 1999;83:540-545.
50. El-Bradey MH, Cheng L, Song MK, et al. Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach. Retina. 2004;24:376-382.
51. Dalessandro L, Bottaro E. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis. 2002;34:780-782.
52. Kosobucki BR, Goldberg DE, Bessho K, et al. Valganciclovir therapy for immune recovery uveitis complicated by macular edema. Am J Ophthalmol. 2004;137: 636-638.
53. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73-83.
54. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(suppl 1):S3-S28.
55. Matoba A. Ocular viral infections. Pediatr Infect Dis. 1984;3:358-368.
56. Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol. 2005;24:205-213.
57. Scott FT, Leedham-Green ME, Barrett-Muir WY, et al. A study of zoster and the development of postherpetic neuralgia in East London. J Med Virol. 2003; 70(suppl 1):S24-S30.
58. Ragozzino MW, Melton LJ III, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine. 1982;61:310-316.
59. Tyndall MW, Nasio J, Agoki E, et al. Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya. Clin Infect Dis. 1995;21: 1035-1037.
60. Khan AO, Al-Assiri A, Wagoner MD. Ring corneal infiltrate and progressive ring thinning following primary varicella infection. J Pediatr Ophthalmol Strabismus. 2008; 45:116-117.
61. Fernández de Castro LE, Sarraf OA, Hawthorne KM, et al. Ocular manifestations after primary varicella infection. Cornea. 2006;25:866-867.
62. Kestelyn P, Stevens AM, Bakkers E, et al. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol. 1987; 71:806-809.
63. van der Lelij A, Ooijman FM, Kijlstra A, et al. Anterior uveitis with sectoral iris atrophy in the absence of keratitis. Ophthalmology. 2000;107:1164-1170.
64. Ganatra JB, Chandler D, Santos C, et al. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000;129:166-172.
65. van Gelder RN, Willig JL, Holland GN, et al. Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients. Ophthalmology. 2001;108: 869-876.
66. Landry ML, Mullangi P, Nee P, et al. Herpes simplex virus type 2 acute retinal necrosis 9 years after neonatal herpes. J Pediatr. 2005;146:836-838.
67. Curtis TH, Mandava N. Acute retinal necrosis as a late sequela of herpes simplex type 1 encephalitis in a child. J AAPOS. 2007;11:509-510.
68. Young NJ, Bird AC. Bilateral acute retinal necrosis. Br J Ophthalmol. 1978;62: 581-590.
69. Engstrom RE Jr, Holland GN, Margolis TP. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994;101:1488-1502.
70. Margolis R, Brasil OF, Lowder CY, et al. Multifocal posterior necrotizing retinitis. Am J Ophthalmol. 2007;143:1003-1008.
71. Bodaghi B, Rozenberg F, Cassoux N, et al. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis. Ophthalmology. 2003;110:1737-1743.
72. Sudesh S, Laibson PR. The impact of the Herpetic Eye Disease Studies on the management of herpes simplex virus ocular infections. Curr Opin Ophthalmol. 1999; 10:230-233.
73. Wilhelmus KR. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2008;23:CD002898.
74. Zambarakji HJ, Obi AA, Mitchell SM. Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocul Immunol Inflamm. 2002;10:41-46.
75. Spaide RF, Martin DF, Teich SA, et al. Successful treatment of progressive outer retinal necrosis syndrome. Retina. 1996;16:479-487.
76. Roig-Melo EA, Macky TA, Heredia-Elizonda ML, et al. Progressive outer retinal necrosis syndrome: successful treatment with a new combination of antiviral drugs. Eur J Ophthalmol. 2001;11:200-202.
77. Chau Tran TH, Cassoux N, Bodaghi B, et al. Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis. Ocul Immunol Inflamm. 2003;11:141-144.
78. Aizman A, Johnson MW, Elner SG. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology. 2007;114:307-312.
79. Emerson GG, Smith JR, Wilson DJ, et al. Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology. 2006;113:2259-2261.
80. Gnann J. Antiviral therapy for herpes zoster. Herpes. 2006;13(suppl 1):16A-20A.
81. Svahn A, Berggren J, Parke A, et al. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol. 2006;37:118-123.
82. Kangro HO, Osman HK, Lau YL, et al. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol. 1994;43:91-96.
83. Tsai WS, Chang MH, Chen JY, et al. Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1989;30:81-86.
84. Chodosh J, Gan YJ, Sixbey JW. Detection of Epstein-Barr virus genome in ocular tissues. Ophthalmology. 1996;103:687-690.
85. Crouse CA, Pflugfelder SC, Pereira I, et al. Detection of herpes viral genomes in normal and diseased corneal epithelium. Curr Eye Res. 1990;9:569-581.
86. Raymond LA, Wilson CA, Linnemann CC Jr, et al. Punctate outer retinitis in acute Epstein-Barr virus infection. Am J Ophthalmol. 1987;104:424-426.
87. Kelly SP, Rosenthal AR, Nicholson KG, et al. Retinochoroiditis in acute Epstein-Barr virus infection. Br J Ophthalmol. 1989;73:1002-1003.
88. Reinhard T, Adams O, Sundmacher R. Detection of the Epstein-Barr virus genome in the anterior chamber of a patient with chronic keratouveitis. Acta Ophthalmol Scand. 2003;81:671-673.
89. Heiligenhaus A, Dohrmann J, Koch J, et al. Severe bilateral panuveitis in a patient with asymptomatic Epstein-Barr virus infection. Eye. 2001;15:792-793.
90. Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis. Features management and outcomes. Ophthalmology. 2007;114:756-762.
91. Kase S, Namba K, Kitaichi N, et al. Epstein-Barr virus infected cells in the aqueous humour originated form nasal NK/Tcell lymphoma. Br J Ophthalmol. 2006;90:244-245.
92. Freigassner P, Ardjomand N, Radner H, et al. Coinfection of the retina by Epstein-Barr virus and cytomegalovitus in an AIDS patient. Am J Ophthalmol. 2002;134:275-277.
93. Ho SF, Fink C, Murray PI. Epstein-Barr Virus DNA quantification: an adjunctive diagnostic marker for AIDS-associated lymphoma. Ocul Immunol Inflamm. 2005;13: 471-473.
94. Rohrbach JM, Kröber SM, Teufel T, et al. EBV-induced polymorphic lymphoproliferative disorder of the iris after heart transplantation. Graefes Arch Clin Exp Ophthalmol. 2004;242:44-50.
95. Colby BM, Shaw JE, Elion GB, et al. Effect of acyclovir [9-(2-hydroxyethoxymethyl)- guanine] on Epstein-Barr virus DNA replication. J Virol. 1980;34:560-568.
96. Allen U, Alfieri C, Preiksaitis J, et al. Epstein-Barr virus infection in transplant recipients: summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis. 2002;13:89-99.
97. Robertson SE, Featherstone DA, Gacic-Dobo M, et al. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica. 2003;14:306-315.
98. Yusof AB, Selvanesan S, Norizah I, et al. Rubella outbreak amongst residential students in a military vocational school of Malaysia. Med J Malaysia. 2006;61:296-301.
99. Puthavathana P, Wasi C, Kositanont U, et al. Rubella outbreak in Thailand 1983- 1984: a study at Siriraj Hospital. Southeast Asian J Trop Med Public Health. 1985;16: 207-213.
100. Hahne SJ, Abbink F, van Binnendijk RS, et al. Rubella epidemic in the Netherlands, 2004/05: awareness of congenital rubella syndrome required. Ned Tijdschr Geneeskd. 2005;149:1174-1178.
101. de Visser L, Braakenburg A, Rothova A, et al. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol. 2008;146:292-297.
102. Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humour. Am J Ophthalmol. 2004;138:46-54.
103. Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144:424-428.
104. Biswas J, Narayana KM, Gupta S, et al. Panuveitis due to acquired rubella and isolation of rubella virus from the aqueous humour. J Pediatr Ophthalmol Strabismus. 2003;40:240-242.
105. Jain M, Rai S, Chakravarti A. Chikungunya: a review. Trop Doct. 2008;38:70-72.
106. Mahendradas P, Ranganna SK, Shetty R, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115:287-291.
107. Lalitha P, Rathinam S, Banushree K, et al. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144: 552-556.
108. Mittal A, Mittal S, Bharati J, et al. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381-1386.